XENE logo

XENON PHARMACEUTICALS INC

XENENASDAQ
🏆 #1003 by market capEarnings Nov 2US Equity
$887.73▲ $57.44 (+6.47%)
Simulated price
1h—
24h▲ 6.5%
7d—
14d—
30d—
1y—
🏦Market Cap
$6.11B
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
64
Fair
📊

Analyst Ratings

Price
$887.73
Total
22
Raised
0
Lowered
0
Avg PT
$84.09
H / L
$100 / $60
InstitutionActionRatingDate
JP Morgan
ReiteratedOverweight2026-05-27
Needham
ReiteratedBuy2026-05-08
RBC Capital
ReiteratedOutperform2026-05-08
Wedbush
ReiteratedOutperform2026-03-16
Deutsche Bank
ReiteratedBuy2026-03-10
HC Wainwright & Co.
ReiteratedBuy2026-03-10
Wells Fargo
ReiteratedOverweight2026-03-10
Baird
ReiteratedOutperform2026-03-09
Chardan Capital
ReiteratedBuy2025-10-07
Goldman Sachs
ReiteratedBuy2025-04-17
Cantor Fitzgerald
ReiteratedOverweight2024-08-09
Citigroup
ReiteratedBuy2024-05-10
B of A Securities
ReiteratedBuy2024-01-02
Stifel
ReiteratedBuy2023-12-18
Guggenheim
ReiteratedBuy2023-06-15
Cowen & Co.
ReiteratedOutperform2022-12-12
Raymond James
ReiteratedOutperform2022-10-19
SVB Leerink
ReiteratedOutperform2022-08-11
William Blair
ReiteratedOutperform2020-01-08
Stifel Nicolaus
ReiteratedBuy2018-08-08
Jefferies
ReiteratedBuy2016-03-09
Canaccord Genuity
ReiteratedBuy2015-07-02
One row per institution, most recent rating